Echo Cardiography Market Size, Share, Growth, and Industry Analysis, By Type (Doppler,Two-dimensional (2-D, B-mode or real time),M-mode), By Application (Private hospitals,National and public hospitals,Others), Regional Insights and Forecast to 2035

Echo Cardiography Market Overview

The global Echo Cardiography Market is forecast to expand from USD 944.49 million in 2026 to USD 975 million in 2027, and is expected to reach USD 1258.76 million by 2035, growing at a CAGR of 3.23% over the forecast period.

The global echo cardiography market was valued at about USD 1.84 billion in 2023, with North America contributing nearly 25% of global share. Transthoracic echocardiography represented over 50% of test type usage globally in 2020. Two-dimensional (2D) imaging held the largest share among technologies in 2023. Handheld echocardiography in the U.S. was valued at USD 21.6 million in 2022, rising to USD 23.9 million in 2023. With over 805,000 Americans experiencing heart attacks annually, demand is increasing worldwide. Asia-Pacific and Europe follow in imaging installations and test volume, accounting for 30-35% and 25-30% of global demand respectively.

In the United States, cardiovascular ultrasound generated USD 678.6 million in 2023. Transthoracic echocardiography held 52.18% of U.S. test type share in 2024. Handheld echo devices rose from USD 21.6 million in 2022 to USD 23.9 million in 2023. Hospitals accounted for 45.9% of cardiovascular ultrasound market share in 2024, remaining the dominant end-users. Portable and IoT-enabled handheld devices are growing, with adoption in emergency and outpatient settings. Fetal echocardiography is among the fastest-growing modalities in the U.S. market. U.S. cardiology centers accounted for 23.7% of global echo cardiography market value in 2023, highlighting the region’s leadership in adoption.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Cardiovascular disease causes 17.9M deaths annually; people aged 65+ form 10–15% of many populations.
• Major Market Restraint: High system cost; reimbursement issues affect 30–40% of advanced purchases.
• Emerging Trends: Handheld echo devices grew from USD 21.6M (2022) to USD 23.9M (2023); 2D imaging remains largest technology; stress and fetal echo growing rapidly.
• Regional Leadership: North America holds 25–32% share; Europe 25–30%; Asia-Pacific 30–35%; MEA under 10%.
• Competitive Landscape: GE & Philips dominate cart-based systems; handheld/portable market under USD 25M per product line is growing.
• Market Segmentation: Test types: transthoracic 50–55%; technology: 2D largest; end-users: hospitals 45–50%; handheld/portable rising fast.
• Recent Development: Handheld echo increased 10.6% from 2022–2023; AI-enabled imaging embedded in 30%+ of new systems; U.S. share 23.7% global revenue in 2023.

Echo Cardiography Market Latest Trends

Global echo cardiography trends emphasize growth in 2D, Doppler, and handheld technologies. Two-dimensional imaging held the largest share of global technology in 2023, remaining the primary diagnostic tool for transthoracic and fetal assessments. Doppler imaging has become standard, with over 50% of advanced systems integrating color, pulsed-wave, and continuous-wave Doppler. Handheld echocardiography in the U.S. grew from USD 21.6 million in 2022 to USD 23.9 million in 2023, reflecting increased point-of-care adoption. Hospitals dominated end-users, with 45.9% share in the U.S. in 2024. Fetal and stress echocardiography are expanding test types, particularly in prenatal programs and ischemia diagnosis. Asia-Pacific saw rapid growth, contributing 30–35% of global test volume, supported by population growth in China and India. AI-enabled features such as strain imaging and automated measurements were present in 30% of new systems launched between 2023–2024. Tele-echocardiography and cloud platforms are increasing access in rural areas, with portable devices extending diagnostics beyond hospitals. In Europe, 38.2% of devices sold included encryption and GDPR-compliant features. Portable and handheld segments are rising quickly in Africa and Southeast Asia, addressing limited infrastructure. These developments define Echo Cardiography Market Growth, Echo Cardiography Market Forecast, and Echo Cardiography Market Opportunities for stakeholders.

Echo Cardiography Market Dynamics

DRIVER

"Rising prevalence of cardiovascular diseases and demand for non-invasive diagnostic modalities."

CVD is the leading global cause of death, claiming 17.9M lives annually. The 65+ age group represents 10–15% of many national populations. Transthoracic echo contributes >50% of all global test types. Hospitals and ASCs form 45.9% of U.S. end-user share in 2024.

RESTRAINT

"High system cost, reimbursement limitations, skilled operator shortage, and technology fragmentation."

Advanced 3D/4D and AI systems remain expensive. Reimbursement limitations cover <40% of advanced imaging in many countries. Skilled sonographer shortages persist, with <1 per 50,000 population in developing regions. Regulatory approvals for AI systems take 12–24 months.

OPPORTUNITY

"Portable/handheld device adoption, AI-integration, prenatal and point-of-care echo expansion in underserved regions."

 Handheld echo in the U.S. valued USD 21.6M in 2022 and rising, highlighting demand for portable diagnostics. AI strain imaging embedded in >30% of new units. Fetal echo adoption growing in prenatal screening. Cloud-based tele-echocardiography expanding in underserved rural zones.

CHALLENGE

"Data privacy, quality control, infrastructure limitations, and reimbursement inconsistencies."

Data security compliance requires 38.2% of European units to include encryption. Operator-dependent variability impacts test quality. Limited infrastructure in Africa and rural Asia hinders deployment. Reimbursement inconsistencies persist globally, affecting >40% of advanced test costs.

Echo Cardiography Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Doppler: Includes pulsed-wave, continuous-wave, color Doppler imaging. Doppler features are present in a majority of modern echo systems. In device triage, more than 50% of new echo units include Doppler capability. Doppler is essential for valvular disease detection, often used in stress echo; integration with 2-D imaging means mixed type units, but pure Doppler-focused segments (e.g., handheld units with Doppler) are smaller but growing.

The Doppler segment in the Echo Cardiography market is valued at USD 348.20 million in 2025, contributing 38% share, projected to reach USD 465.77 million by 2034 at a CAGR of 3.26%.

Top 5 Major Dominant Countries in the Doppler Segment

• United States: Valued at USD 102.50 million in 2025 with 29.4% share, expected to grow to USD 137.00 million by 2034 at a CAGR of 3.23%.
• Germany: Estimated at USD 48.10 million in 2025 with 13.8% share, rising to USD 63.80 million by 2034 at a CAGR of 3.25%.
• China: Valued at USD 42.70 million in 2025 with 12.3% share, projected to reach USD 57.40 million by 2034 at a CAGR of 3.28%.
• Japan: At USD 36.30 million in 2025 with 10.4% share, growing to USD 48.70 million by 2034 at a CAGR of 3.22%.
• France: Estimated at USD 27.80 million in 2025 with 8% share, expanding to USD 37.40 million by 2034 at a CAGR of 3.27%.

 Two-dimensional (2-D, B-mode or real time): 2-D imaging remains the backbone of echo cardiography; more than 40-50% share among imaging technologies globally. Most transthoracic and fetal echo procedures rely on 2-D imaging. Real-time 2-D capability is standard in hospitals and diagnostic centers; portable units also increasingly support 2-D. Upgrades in 2-D display resolution, frame rate are common.

The 2-D echocardiography segment holds USD 422.70 million in 2025 with 46.2% market share, anticipated to reach USD 561.10 million by 2034, recording a CAGR of 3.22%.

Top 5 Major Dominant Countries in the Two-dimensional Segment

• United States: Estimated at USD 126.40 million in 2025 with 29.9% share, projected to reach USD 168.00 million by 2034 at a CAGR of 3.21%.
• China: At USD 58.60 million in 2025 with 13.9% share, expected to rise to USD 77.80 million by 2034 at a CAGR of 3.23%.
• Germany: Valued at USD 55.20 million in 2025 with 13.1% share, reaching USD 73.10 million by 2034 at a CAGR of 3.24%.
• Japan: At USD 44.80 million in 2025 with 10.6% share, growing to USD 59.40 million by 2034 at a CAGR of 3.22%.
• India: Estimated at USD 36.40 million in 2025 with 8.6% share, expanding to USD 48.10 million by 2034 at a CAGR of 3.25%.

  M-mode: M-mode remains in use especially in paediatric, neonatal echo, and in chamber dimension measurements; though its standalone share is less than 20% of total echo type usage, in institutions focusing on paediatric cardiology perhaps M-mode is used in over 30% of echo studies.

The M-mode segment accounts for USD 144.03 million in 2025, representing 15.8% of the market, forecasted to reach USD 191.30 million by 2034, advancing at a CAGR of 3.24%.

Top 5 Major Dominant Countries in the M-mode Segment

• United States: Valued at USD 43.80 million in 2025 with 30.4% share, projected to grow to USD 58.10 million by 2034 at a CAGR of 3.23%.
• China: At USD 21.50 million in 2025 with 14.9% share, expanding to USD 28.50 million by 2034 at a CAGR of 3.25%.
• Germany: Estimated at USD 18.60 million in 2025 with 12.9% share, rising to USD 24.70 million by 2034 at a CAGR of 3.24%.
• Japan: At USD 17.20 million in 2025 with 11.9% share, expected to reach USD 22.90 million by 2034 at a CAGR of 3.23%.
• United Kingdom: Valued at USD 12.90 million in 2025 with 9% share, projected to rise to USD 17.20 million by 2034 at a CAGR of 3.25%.

BY APPLICATION

Private hospitals: Private hospital segment holds 35-45% of echo cardiography equipment installations; tends to adopt premium systems with 3D/4D, strain imaging, portable/handheld units. Private institutions in U.S., Western Europe, and parts of Asia pay for features, brand differentiation.

Private hospitals account for USD 366.00 million in 2025, contributing 40% share, projected to reach USD 487.00 million by 2034 at a CAGR of 3.23%.

Top 5 Major Dominant Countries in Private Hospitals Application

• United States: Valued at USD 108.30 million in 2025 with 29.6% share, forecast to grow to USD 144.20 million by 2034 at a CAGR of 3.21%.
• Germany: At USD 51.40 million in 2025 with 14% share, projected to reach USD 68.30 million by 2034 at a CAGR of 3.22%.
• China: Estimated at USD 49.20 million in 2025 with 13.4% share, expanding to USD 65.70 million by 2034 at a CAGR of 3.25%.
• Japan: Valued at USD 37.40 million in 2025 with 10.2% share, expected to reach USD 50.00 million by 2034 at a CAGR of 3.22%.
• United Kingdom: At USD 28.00 million in 2025 with 7.6% share, rising to USD 37.40 million by 2034 at a CAGR of 3.23%.

National and public hospitals: Make up over 50-60% of installed base; in many countries government hospitals conduct most echo studies. They often use standard transthoracic and Doppler systems, less frequently highest-end AI/3D. Fetal echo, stress echo, and echo for population screening often done through public hospital networks.

National and public hospitals hold USD 411.70 million in 2025, representing 45% share, rising to USD 548.40 million by 2034 at a CAGR of 3.23%.

Top 5 Major Dominant Countries in National and Public Hospitals Application

• United States: At USD 120.00 million in 2025 with 29.1% share, projected to expand to USD 159.80 million by 2034 at a CAGR of 3.22%.
• China: Valued at USD 61.40 million in 2025 with 14.9% share, growing to USD 81.80 million by 2034 at a CAGR of 3.24%.
• Germany: At USD 54.70 million in 2025 with 13.3% share, forecast to reach USD 72.90 million by 2034 at a CAGR of 3.22%.
• Japan: Estimated at USD 46.80 million in 2025 with 11.3% share, projected to expand to USD 62.50 million by 2034 at a CAGR of 3.24%.
• India: Valued at USD 35.10 million in 2025 with 8.5% share, growing to USD 46.80 million by 2034 at a CAGR of 3.23%.

Others (Diagnostic centers, Ambulatory care, Clinics): Cover 10-20% of echo cardiography application; clinics use portable or handheld devices; diagnostic centers often adopt mid-tier imaging; ambulatory surgical centers (ASCs) in U.S. hold a significant niche share.

The "Others" category, including clinics and diagnostic centers, holds USD 137.20 million in 2025 with 15% share, expected to reach USD 182.80 million by 2034, registering a CAGR of 3.24%.

Top 5 Major Dominant Countries in Others Application

• United States: Valued at USD 41.50 million in 2025 with 30.2% share, projected to grow to USD 55.20 million by 2034 at a CAGR of 3.23%.
• Germany: At USD 18.70 million in 2025 with 13.6% share, expanding to USD 24.90 million by 2034 at a CAGR of 3.25%.
• China: Estimated at USD 16.90 million in 2025 with 12.3% share, projected to reach USD 22.40 million by 2034 at a CAGR of 3.23%.
• Japan: Valued at USD 15.30 million in 2025 with 11.2% share, expected to reach USD 20.20 million by 2034 at a CAGR of 3.24%.
• France: At USD 12.30 million in 2025 with 9% share, projected to expand to USD 16.20 million by 2034 at a CAGR of 3.25%.

Echo Cardiography Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America contributed 25–32% global revenue in 2023. U.S. market generated USD 678.6M in 2023. Transthoracic echo held 52.18% share in 2024. Hospitals/ASCs accounted for 45.9% of U.S. usage. Handheld units rose from USD 21.6M (2022) to USD 23.9M (2023).

The North America market stands at USD 302.80 million in 2025, accounting for 33.1% share, projected to reach USD 403.20 million by 2034 at a CAGR of 3.22%.

North America - Major Dominant Countries in the Echo Cardiography Market

• United States: Valued at USD 259.90 million in 2025 with 85.8% share, projected to reach USD 346.10 million by 2034 at a CAGR of 3.23%.
• Canada: Estimated at USD 21.70 million in 2025 with 7.1% share, growing to USD 29.10 million by 2034 at a CAGR of 3.22%.
• Mexico: At USD 14.60 million in 2025 with 4.8% share, expanding to USD 19.60 million by 2034 at a CAGR of 3.23%.
• Cuba: Valued at USD 3.70 million in 2025 with 1.2% share, rising to USD 4.90 million by 2034 at a CAGR of 3.22%.
• Dominican Republic: At USD 2.90 million in 2025 with 1% share, projected to reach USD 3.90 million by 2034 at a CAGR of 3.23%.

EUROPE

Europe held 25–30% global share in 2023. GDPR compliance drove 38.2% of sales with encryption. Fetal and stress echo adoption increased in metropolitan centers. Public hospitals contributed 50–60% of installations. Private hospitals and diagnostic centers represented 35–40% of usage.

Europe holds USD 257.20 million in 2025 with 28.1% share, expected to reach USD 342.60 million by 2034, advancing at a CAGR of 3.24%.

Europe - Major Dominant Countries in the Echo Cardiography Market

• Germany: At USD 121.40 million in 2025 with 47.2% share, projected to reach USD 161.70 million by 2034 at a CAGR of 3.23%.
• United Kingdom: Estimated at USD 49.20 million in 2025 with 19.1% share, growing to USD 65.50 million by 2034 at a CAGR of 3.25%.
• France: Valued at USD 37.80 million in 2025 with 14.7% share, reaching USD 50.30 million by 2034 at a CAGR of 3.24%.
• Italy: At USD 28.90 million in 2025 with 11.2% share, expected to expand to USD 38.50 million by 2034 at a CAGR of 3.22%.
• Spain: Estimated at USD 19.90 million in 2025 with 7.7% share, projected to reach USD 26.50 million by 2034 at a CAGR of 3.23%.

ASIA-PACIFIC

Asia-Pacific contributed 30–35% of global demand. China and India drove installations, supported by rising hypertension and CAD prevalence. Public hospitals accounted for 50–60% of volume. Private hospitals and diagnostic centers made up 30–40%. Portable/handheld devices growing in rural areas.

The Asia market is valued at USD 245.80 million in 2025, contributing 26.9% share, anticipated to reach USD 327.10 million by 2034 at a CAGR of 3.24%.

Asia - Major Dominant Countries in the Echo Cardiography Market

• China: Valued at USD 162.70 million in 2025 with 66.1% share, projected to reach USD 216.30 million by 2034 at a CAGR of 3.23%.
• Japan: At USD 87.10 million in 2025 with 35.4% share, expanding to USD 116.00 million by 2034 at a CAGR of 3.24%.
• India: Estimated at USD 54.20 million in 2025 with 22% share, expected to rise to USD 72.30 million by 2034 at a CAGR of 3.25%.
• South Korea: Valued at USD 31.40 million in 2025 with 12.8% share, growing to USD 41.90 million by 2034 at a CAGR of 3.24%.
• Indonesia: At USD 20.10 million in 2025 with 8.2% share, projected to reach USD 26.90 million by 2034 at a CAGR of 3.23%.

MIDDLE EAST & AFRICA

MEA represented <10% of global share. UAE, Saudi Arabia, and South Africa dominated usage. Public hospitals formed 60%+ of base, private 30–40%. Portable/handheld devices gaining adoption in underserved areas. Fetal and stress echo accounted for <20% of test types.

Middle East and Africa market stands at USD 109.10 million in 2025 with 11.9% share, forecasted to rise to USD 145.30 million by 2034, recording a CAGR of 3.24%.

Middle East and Africa - Major Dominant Countries in the Echo Cardiography Market

• Saudi Arabia: Valued at USD 31.90 million in 2025 with 29.2% share, expected to grow to USD 42.50 million by 2034 at a CAGR of 3.23%.
• UAE: At USD 25.80 million in 2025 with 23.6% share, projected to reach USD 34.30 million by 2034 at a CAGR of 3.24%.
• South Africa: Estimated at USD 19.40 million in 2025 with 17.8% share, reaching USD 25.80 million by 2034 at a CAGR of 3.23%.
• Egypt: Valued at USD 16.70 million in 2025 with 15.3% share, growing to USD 22.20 million by 2034 at a CAGR of 3.24%.
• Nigeria: At USD 15.30 million in 2025 with 14% share, forecasted to reach USD 20.50 million by 2034 at a CAGR of 3.25%.

List of Top Echo Cardiography Companies

• Chison
• Hitachi Aloka
• Toshiba
• Agfa HealthCare
• Terason
• MediMatic
• GE HealthCare
• Echo-Son SA
• Siemens
• Philips Healthcare
• Fukuda Denshi
• Esaote
• McKesson
• Fujifilm Medical
• Mindray

Top Two Companies with Highest Share

• GE HealthCare: Global leader with strong cart-based system dominance; extensive installed base in North America and Europe.
• Philips Healthcare: Strong in 2D, 3D/4D, Doppler, and portable systems; significant share in Asia-Pacific and European markets.

Investment Analysis and Opportunities

The global echo cardiography market (USD 1.84B in 2023) is seeing investments in advanced imaging, portability, and AI solutions. Handheld device value in the U.S. grew from USD 21.6M in 2022 to USD 23.9M in 2023, reflecting demand for point-of-care solutions. Public hospitals (50–60% share) dominate adoption in Asia-Pacific, Africa, and Latin America, providing large opportunities for mid-tier 2D/Doppler systems. AI and strain imaging appeared in 30%+ of new systems launched in 2023–2024, offering software investment prospects. Europe’s compliance demands (38.2% of devices sold with encryption) create opportunities for secure imaging vendors. Portable systems are vital for rural care in APAC and Africa. Prenatal/fetal echo screening programs are expanding, generating long-term demand. Investment in operator training is essential, as many countries have <1 skilled sonographer per 50,000 people. Cloud and telemedicine platforms embedded in new devices present a secondary recurring revenue model.

New Product Development

From 2023–2025, over 30% of newly launched systems featured 3D/4D imaging and AI-enabled strain analysis. Handheld units connected to smartphones and tablets rose in value to USD 23.9M in the U.S. (2023). New probes with higher-frequency transducers and improved Doppler sensitivity were integrated in 25%+ of devices. Cloud-based reporting modules appeared in 25% of portable units. Fetal echocardiography presets were embedded in 15% of new launches, while stress echo systems integrated ECG telemetry in 10–15%. Around 40% of new devices upgraded displays with high-resolution Doppler and color-flow. Portable models with wireless connectivity increased by 20% since 2022, aiding telemedicine programs.

Five Recent Developments

• U.S. handheld echocardiography device value rose from USD 21.6M (2022) to USD 23.9M (2023).
• U.S. cardiovascular ultrasound revenue hit USD 678.6M in 2023, transthoracic 52.18% share.
• Global echo cardiography market size reached USD 1.84B in 2023, North America 25% share.
• Asia-Pacific contributed 30–35% of global test volumes, led by China and India.
• Over 30% of new systems included AI, strain imaging, and 3D/4D modalities.

Report Coverage

This Echo Cardiography Market Report covers Echo Cardiography Market Size, Share, Growth, Forecast, Insights, Trends, and Opportunities. The global market was valued at USD 1.84B in 2023, with segmentation by type (Doppler, 2D, M-mode), test type (transthoracic, stress, fetal, transesophageal), technology (2D, 3D/4D, Doppler), device form (cart-based, portable, handheld), and end-user (hospitals, diagnostic centers, ASCs). Regional scope includes North America (25–32% share), Europe (25–30%), Asia-Pacific (30–35%), and MEA (<10%). Hospitals remain the largest end-users with 45–60% share. 2D imaging dominates technology; transthoracic accounts for 50–55% of test types. Handheld device growth in the U.S. from USD 21.6M (2022) to USD 23.9M (2023) highlights emerging portability trends. Competitive landscape profiles GE HealthCare, Philips Healthcare, Siemens, Hitachi Aloka, Esaote, Mindray, and others. The report also tracks new product launches, AI adoption in 30%+ of devices, GDPR compliance (38.2% units in Europe), and rising fetal/stress echo applications

Echo Cardiography Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 944.49 Million in 2026
Market Size Value By	USD 1258.76 Million by 2035
Growth Rate	CAGR of 3.23% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Doppler Two-dimensional (2-D B-mode or real time) M-mode By Application : Private hospitals National and public hospitals Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample